Oxygen Reserve Index & Prevention of Hyperoxemia

Status Completed

Clinical Trial Summary

In patients under general anesthesia, the oxygen level (FiO2) used in inspiration is usually adjusted by monitoring the peripheral oxygen saturation level (SpO2). As a non-invasive method, SpO2 monitoring is known as one of the required methods that can be used to adjust FiO2 and detect and treat hypoxemia. While SpO2 approaching 100% matches the value of 128 mmHg in arterial partial oxygen pressure (PaO2), in cases where PaO2 increases more, the investigators cannot follow this situation with SpO2 and cannot prevent hyperoxemia. As stated in the literature, hyperoxemia has positive effects in general anesthesia and intensive care, as well as negative effects such as increased inflammation, oxidative stress and ischemia-reperfusion. In addition, acute lung injury, development of atelectasis, increased mortality, and critical illness rates have been associated with hyperoxemia in many publications. The only way the investigators can use to measure the level of hyperoxemia seems to be arterial blood gas analysis, and this method limits the investigators use because it is invasive. The Oxygen Reserve Index (ORi™) (Masimo Corp., Irvine, CA, USA) is a variable related to real-time oxygenation reserve status in the mildly hyperoxemic range (approximately 100 - 200 mmHg PaO2). ORi can be defined as a multi-wavelength, noninvasive pulse co-oximetry sensor. ORi is a dimensionless index ranging from 0.00 (no reserve) to 1.00 (maximum reserve) depending on the oxygenation reserve status. There are very few studies in the literature using ORi to detect hyperoxemia. The investigators thought that if FiO2 levels used in preoxygenation, anesthesia maintenance and recovery stages in day surgeries were correlated with ORi levels, a threshold value could be determined for FiO2 levels during anesthesia stages in cases where invasive arterial blood gas could not be followed. This study aims to determine the relationship between SpO2, FiO2 and ORi during general anesthesia, to investigate the usefulness of ORi in determining the FiO2 threshold value during anesthesia stages as an indicator of hyperoxemia, and to investigate the effects of these values on the hemodynamics, recovery, agitation and nausea-vomiting states of the patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05505032
Study type	Interventional
Source	Baskent University Ankara Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	August 17, 2022
Completion date	October 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04291911` - Retrospective Multicentre Observational Study on the Incidence of Hyperoxia in Non-intubated Patients in Intensive Care in Belgium Study OxSIZgen
Completed	`NCT02917668` - Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients	N/A
Not yet recruiting	`NCT02201875` - Intrinsic Periodic Pattern of Breathing	N/A
Completed	`NCT05770583` - The Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia.	N/A
Not yet recruiting	`NCT02553668` - Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression	N/A
Completed	`NCT01978158` - Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α	Phase 1/Phase 2
Completed	`NCT03268590` - Neuroimaging During Pure Oxygen Breathing	Phase 4
Active, not recruiting	`NCT04133740` - Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study	Phase 4
Recruiting	`NCT04866342` - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor	N/A
Completed	`NCT05150418` - Supplemental Oxygen in Hypovolemia	Phase 1
Terminated	`NCT03550469` - Computer-assisted Oxygen Therapy Weaning in Critically Ill Children	N/A
Recruiting	`NCT04413097` - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants	N/A
Completed	`NCT03464695` - Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD	N/A
Recruiting	`NCT04269161` - NICU Oxygen Control Study	N/A
Completed	`NCT02384616` - Hyperoxygenation in Anesthetized Children	N/A
Unknown status	`NCT01348906` - Intermittent Normoxia Reduces Myocardial Reperfusion Injury	N/A
Completed	`NCT04420897` - The Effect of Intraoperative Arterial Oxygen Pressures on Early Post-Operative Patient and Graft Survival in Living Donor Kidney Transplantation
Completed	`NCT03930979` - The Effect of Hyperoxia on Cardiac Output
Not yet recruiting	`NCT06326372` - The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
Recruiting	`NCT05412810` - Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL).

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Oxygen Reserve Index and Prevention of Hyperoxemia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms